Dr. Namrata Singh, CLEAR Center affiliate, received a spotlight by Rheumatology Advisor: “Frailty Predicts Poor Outcomes With b/tsDMARD Treatment in Rheumatoid Arthritis”. Read that spotlight here.
Dr. Singh led a team including several faculty and staff with the CLEAR Center to study Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs. Join us in congratulating her and the team in receiving this special recognition.